• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像引导的纳米诊疗剂递药用于肺癌的靶向治疗。

Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy.

机构信息

Department of Oncology, The Second Affiliate Hospital of Xi'an Jiaotong University; Xi'an, Shaanxi, 710004, China.

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School; Boston, MA 02114, USA.

出版信息

Theranostics. 2022 May 13;12(9):4147-4162. doi: 10.7150/thno.72803. eCollection 2022.

DOI:10.7150/thno.72803
PMID:35673583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9169367/
Abstract

Enormous efforts have been made to integrate various therapeutic interventions into multifunctional nanoplatforms, resulting in the advance of nanomedicine. Image-guided drug delivery plays a pivotal role in this field by providing specific targeting as well as image navigation for disease prognosis. We demonstrate image-guided surgery and drug delivery for the treatment of lung cancer using nanotheranostic H-dots loaded with gefitinib and genistein. The surgical margin for lung tumors is determined by image guidance for precise tumor resection, while targeted anti-cancer drugs function simultaneously for synergistic combination therapy. Compared to conventional chemotherapies, H-dot complexes could improve the therapeutic efficacy of drugs while reducing the risk of adverse effects and drug resistance owing to their ideal biodistribution profiles, high targetability, low nonspecific tissue uptake, and fast renal excretion. These H-dot complexes have unlocked a unique framework for integrating multiple therapeutic and diagnostic modalities into one nanoplatform.

摘要

已经做出了巨大的努力将各种治疗干预整合到多功能纳米平台中,从而推进了纳米医学的发展。图像引导的药物输送在该领域中起着关键作用,它为疾病的预后提供了特定的靶向和图像导航。我们使用载有吉非替尼和染料木黄酮的纳米治疗 H 点来演示用于治疗肺癌的图像引导手术和药物输送。通过图像引导来确定肺肿瘤的手术边界,以进行精确的肿瘤切除,同时靶向抗癌药物同时发挥作用,进行协同联合治疗。与传统化疗相比,由于 H 点复合物具有理想的生物分布、高靶向性、低非特异性组织摄取和快速肾脏排泄等特点,因此可以提高药物的治疗效果,同时降低不良反应和耐药性的风险。这些 H 点复合物为将多种治疗和诊断方式整合到一个纳米平台中开辟了独特的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/e82d28b64b64/thnov12p4147g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/4700a6ad83d6/thnov12p4147g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/200f7c2ecd80/thnov12p4147g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/c4d607902b65/thnov12p4147g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/e7f8ff80ffc5/thnov12p4147g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/5218fe66e858/thnov12p4147g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/2f0818372a3e/thnov12p4147g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/a94995e81856/thnov12p4147g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/e82d28b64b64/thnov12p4147g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/4700a6ad83d6/thnov12p4147g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/200f7c2ecd80/thnov12p4147g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/c4d607902b65/thnov12p4147g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/e7f8ff80ffc5/thnov12p4147g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/5218fe66e858/thnov12p4147g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/2f0818372a3e/thnov12p4147g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/a94995e81856/thnov12p4147g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f2/9169367/e82d28b64b64/thnov12p4147g008.jpg

相似文献

1
Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy.影像引导的纳米诊疗剂递药用于肺癌的靶向治疗。
Theranostics. 2022 May 13;12(9):4147-4162. doi: 10.7150/thno.72803. eCollection 2022.
2
Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors.用于胃肠道间质瘤的肾脏可清除治疗性纳米平台。
Adv Mater. 2020 Feb;32(6):e1905899. doi: 10.1002/adma.201905899. Epub 2019 Dec 18.
3
Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.聚合物纳米平台在癌症治疗中的最新进展:智能输送系统(SDS)、纳米治疗和多药耐药(MDR)抑制。
Biomed Mater. 2023 Nov 27;19(1). doi: 10.1088/1748-605X/ad0b23.
4
Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.用于增强腹腔给药后靶向和图像引导药物递送至腹膜肿瘤的肿瘤穿透治疗诊断纳米颗粒。
Theranostics. 2017 Apr 10;7(6):1689-1704. doi: 10.7150/thno.18125. eCollection 2017.
5
Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.利用肽适体靶向聚合物作为一种模型纳米药物来研究癌症纳米诊疗中的药物分布。
Mol Pharm. 2017 Oct 2;14(10):3539-3549. doi: 10.1021/acs.molpharmaceut.7b00560. Epub 2017 Sep 7.
6
Tumor-targeted nanomedicines for cancer theranostics.用于癌症诊疗的肿瘤靶向纳米药物。
Pharmacol Res. 2017 Jan;115:87-95. doi: 10.1016/j.phrs.2016.11.014. Epub 2016 Nov 16.
7
Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.金属有机框架的治疗学:用于临床转化的影像引导纳米医学
Nanomedicine (Lond). 2023 Apr;18(8):695-703. doi: 10.2217/nnm-2022-0278. Epub 2023 Jun 1.
8
Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene- and Photothermal Therapy.基于影像引导的肿瘤靶向递药纳米平台用于联合化疗、基因治疗和光热治疗
Theranostics. 2018 Nov 10;8(20):5662-5675. doi: 10.7150/thno.28241. eCollection 2018.
9
IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.用于胰腺癌靶向及影像引导治疗的IGF1受体靶向诊疗纳米颗粒
ACS Nano. 2015 Aug 25;9(8):7976-91. doi: 10.1021/acsnano.5b01288. Epub 2015 Aug 10.
10
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.采用 HER2 靶向治疗性纳米颗粒的异质性卵巢癌靶向药物递送和图像引导治疗。
Theranostics. 2019 Jan 24;9(3):778-795. doi: 10.7150/thno.29964. eCollection 2019.

引用本文的文献

1
Renal Clearable H-Dots Leveraging Ligand Complexation for Enhanced Active Tumor Targeting.利用配体络合增强主动肿瘤靶向性的可肾清除H点纳米粒子。
Small Sci. 2024 Aug 13;4(11):2400246. doi: 10.1002/smsc.202400246. eCollection 2024 Nov.
2
Lipocalin-2 promotes NSCLC progression by activating the JAK2/STAT3 signaling pathway.脂质运载蛋白-2通过激活JAK2/STAT3信号通路促进非小细胞肺癌进展。
J Transl Med. 2025 Apr 10;23(1):419. doi: 10.1186/s12967-025-06418-1.
3
New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology.

本文引用的文献

1
Overcoming therapy resistance in EGFR-mutant lung cancer.克服 EGFR 突变型肺癌的治疗抵抗。
Nat Cancer. 2021 Apr;2(4):377-391. doi: 10.1038/s43018-021-00195-8. Epub 2021 Apr 15.
2
Degradable mesoporous semimetal antimony nanospheres for near-infrared II multimodal theranostics.可降解介孔半导体锑纳米球用于近红外二区多模式诊疗一体化。
Nat Commun. 2022 Jan 27;13(1):539. doi: 10.1038/s41467-021-27835-y.
3
Antimony Nanopolyhedrons with Tunable Localized Surface Plasmon Resonances for Highly Effective Photoacoustic-Imaging-Guided Synergistic Photothermal/Immunotherapy.
肺癌诊断与治疗的新策略:纳米技术的应用与进展
Biomark Res. 2024 Nov 13;12(1):136. doi: 10.1186/s40364-024-00686-7.
4
Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery.纳米材料驱动的药物输送系统:治疗性给药当前进展与未来方向的全面探索
3 Biotech. 2024 Dec;14(12):289. doi: 10.1007/s13205-024-04135-y. Epub 2024 Nov 4.
5
Gold Nanoparticle Transport in the Injured Kidneys with Elevated Renal Function Biomarkers.肾功能生物标志物升高的损伤肾脏中的金纳米颗粒转运
Adv Mater. 2024 Sep;36(36):e2402479. doi: 10.1002/adma.202402479. Epub 2024 Jul 29.
6
H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs.H 点介导的纳米治疗减轻基于铂的抗癌药物的全身毒性。
Int J Mol Sci. 2023 Oct 23;24(20):15466. doi: 10.3390/ijms242015466.
7
Phototheranostics for multifunctional treatment of cancer with fluorescence imaging.光热治疗癌症的多功能治疗:荧光成像。
Adv Drug Deliv Rev. 2022 Oct;189:114483. doi: 10.1016/j.addr.2022.114483. Epub 2022 Aug 6.
具有可调局域表面等离子体共振的锑纳米多面体用于高效光声成像引导的协同光热/免疫治疗。
Adv Mater. 2021 May;33(18):e2100039. doi: 10.1002/adma.202100039. Epub 2021 Mar 30.
4
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.吉非替尼对比长春瑞滨联合顺铂用于 II-IIIA 期(N1-N2)表皮生长因子受体突变型非小细胞肺癌的辅助治疗:CTONG1104 期 III 临床试验最终总生存分析。
J Clin Oncol. 2021 Mar 1;39(7):713-722. doi: 10.1200/JCO.20.01820. Epub 2020 Dec 17.
5
Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.吉非替尼作为可切除 II-IIIA 期非小细胞肺癌的新辅助治疗:一项 II 期研究。
J Thorac Cardiovasc Surg. 2021 Feb;161(2):434-442.e2. doi: 10.1016/j.jtcvs.2020.02.131. Epub 2020 Mar 19.
6
New insights into the functions of Cox-2 in skin and esophageal malignancies.探讨 Cox-2 在皮肤和食管恶性肿瘤中的功能新见解。
Exp Mol Med. 2020 Apr;52(4):538-547. doi: 10.1038/s12276-020-0412-2. Epub 2020 Apr 1.
7
Efficacy of EGFR-TKIs with or without angiogenesis inhibitors in advanced non-small-cell lung cancer: A systematic review and meta-analysis.表皮生长因子受体酪氨酸激酶抑制剂联合或不联合血管生成抑制剂治疗晚期非小细胞肺癌的疗效:一项系统评价与荟萃分析。
J Cancer. 2020 Jan 1;11(3):686-695. doi: 10.7150/jca.34957. eCollection 2020.
8
Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.染料木黄酮在癌症中的分子作用机制:最新进展
Front Pharmacol. 2019 Dec 6;10:1336. doi: 10.3389/fphar.2019.01336. eCollection 2019.
9
Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors.用于胃肠道间质瘤的肾脏可清除治疗性纳米平台。
Adv Mater. 2020 Feb;32(6):e1905899. doi: 10.1002/adma.201905899. Epub 2019 Dec 18.
10
Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting.聚合物纳米粒子的尺寸依赖性对肿瘤靶向的 EPR 效应。
Adv Healthc Mater. 2020 Jan;9(1):e1901223. doi: 10.1002/adhm.201901223. Epub 2019 Dec 3.